Liver transplantation in HIV patients

Seminars in Liver Disease

Volumn 32, Issue 2, 2012, Pages 177-185

  Fox, Alyson N ^a   Vagefi, Parsia A ^b   Stock, Peter G ^c  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV; liver transplantation; viral hepatitis

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; COTRIMOXAZOLE; CYCLOSPORIN A; DAPSONE; FLUCONAZOLE; HEPATITIS B ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON; RAPAMYCIN; RIBAVIRIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR; VIRUS RNA;

ATYPICAL MYCOBACTERIOSIS; CANDIDIASIS; CD4 LYMPHOCYTE COUNT; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; GENOTYPE; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPROPHYLAXIS; KAPOSI SARCOMA; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TRANSPLANTATION; MIXED INFECTION; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PNEUMOCYSTIS PNEUMONIA; POPULATION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; TREATMENT RESPONSE; VIREMIA; VIRUS REPLICATION;

COINFECTION; DONOR SELECTION; HEPATITIS, VIRAL, HUMAN; HIV; HIV INFECTIONS; HUMANS; LIVER TRANSPLANTATION; PATIENT SELECTION; SEVERITY OF ILLNESS INDEX;

EID: 84863209231     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0032-1316474     Document Type: Conference Paper

References (45)

1. Bica I, McGovern B, Dhar R., et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis: 2001; 32 3 492 497
2. Palella FJ Jr, Baker RK, Moorman AC., et al. HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr: 2006; 43 1 27 34
3. Weber R, Sabin CA, Friis-Moller N., et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med: 2006; 166 15 1632 1641
4. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr: 1993; 6 6 602 610
5. Hernandez MD, Sherman KE. HIV/hepatitis C coinfection natural history and disease progression. Curr Opin HIV AIDS: 2011; 6 6 478 482
6. Ockenga J, Tillmann HL, Trautwein C, Stoll M, Manns MP, Schmidt RE. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol: 1997; 27 1 18 24
7. Thein HH, Yi Q, Dore GJ, Krahn MD. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS: 2008; 22 15 1979 1991
8. Benhamou Y, Bochet M, Di Martino V., et al. The Multivirc Group Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology: 1999; 30 4 1054 1058
9. García-Samaniego J, Rodríguez M, Berenguer J., et al. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol: 2001; 96 1 179 183
10. Ragni MV, Eghtesad B, Schlesinger KW, Dvorchik I, Fung JJ. Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl: 2005; 11 11 1425 1430
11. Murillas J, Rimola A, Laguno M., et al. ESLD-HIV Working Group Investigators. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Liver Transpl: 2009; 15 9 1133 1141
12. Subramanian A, Sulkowski M, Barin B., et al. MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology: 2010; 138 1 159 164
13. Kemmer NM, Sherman KE. Liver transplantation trends in the HIV population. Dig Dis Sci: 2011; 56 11 3393 3398
14. Stock PG, Fung J. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection. Liver Transpl: 2009; 15 9 1003 1006
15. Gordon FH, Mistry PK, Sabin CA, Lee CA. Outcome of orthotopic liver transplantation in patients with haemophilia. Gut: 1998; 42 5 744 749
16. Bouscarat F, Samuel D, Simon F, Debat P, Bismuth H, Saimot AG. An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1. Clin Infect Dis: 1994; 19 5 854 859
17. Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE. Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010. Arch Surg: 2011; 146 9 1052 1059
18. Wertheim JA, Petrowsky H, Saab S, Kupiec-Weglinski JW, Busuttil RW. Major challenges limiting liver transplantation in the United States. Am J Transplant: 2011; 11 9 1773 1784
19. Boyarsky BJ, Hall EC, Singer AL, Montgomery RA, Gebo KA, Segev DL. Estimating the potential pool of HIV-infected deceased organ donors in the United States. Am J Transplant: 2011; 11 6 1209 1217
20. Muller E, Kahn D, Mendelson M. Renal transplantation between HIV-positive donors and recipients. N Engl J Med: 2010; 362 24 2336 2337
21. Stock PG, Roland ME, Carlson L., et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation: 2003; 76 2 370 375
22. Roland ME, Barin B, Carlson L., et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant: 2008; 8 2 355 365
23. Neff GW, Bonham A, Tzakis AG., et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl: 2003; 9 3 239 247
24. Ragni MV, Belle SH, Im K., et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis: 2003; 188 10 1412 1420
25. Norris S, Taylor C, Muiesan P., et al. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl: 2004; 10 10 1271 1278
26. de Vera ME, Dvorchik I, Tom K., et al. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant: 2006; 6 12 2983 2993
27. Duclos-Vallée JC, Féray C, Sebagh M., et al. THEVIC Study Group Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology: 2008; 47 2 407 417
28. Chung RT, Andersen J, Volberding P., et al. AIDS Clinical Trials Group A5071 Study Team Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med: 2004; 351 5 451 459
29. Duclos-Vallée JC, Tateo M, Teicher E., et al. Results of liver transplantation in a large cohort of more than 100 hiv infected patientsa monocentric experience. Abstract presented at: American Associated for the Study of Liver Diseases (AASLD); November 4-8, 2011; San Francisco, CA
30. Kim WR, Poterucha JJ, Kremers WK, Ishitani MB, Dickson ER. Outcome of liver transplantation for hepatitis B in the United States. Liver Transpl: 2004; 10 8 968 974
31. Terrault NA, Carter JT, Carlson L, Roland ME, Stock PG. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transpl: 2006; 12 5 801 807
32. Tateo M, Roque-Afonso AM, Antonini TM., et al. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity. AIDS: 2009; 23 9 1069 1076
33. Coffin CS, Stock PG, Dove LM., et al. Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients. Am J Transplant: 2010; 10 5 1268 1275
34. Chapuis AG, Paolo Rizzardi G, D'Agostino C., et al. Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo. Nat Med: 2000; 6 7 762 768
35. Schwarz A, Offermann G, Keller F., et al. The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantationdata on four cases and review of the literature. Transplantation: 1993; 55 1 95 103
36. Stock PG, Barin B, Murphy B., et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med: 2010; 363 21 2004 2014
37. Di Benedetto F, Di Sandro S, De Ruvo N., et al. First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation. Transplantation: 2010; 89 6 733 738
38. Tricot L, Teicher E, Peytavin G., et al. Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. Am J Transplant: 2009; 9 8 1946 1952
39. Frassetto LA, Browne M, Cheng A., et al. Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. Am J Transplant: 2007; 7 12 2816 2820
40. d'Arminio Monforte A, Cozzi-Lepri A, Castagna A., et al. Icona Foundation Study Group Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis. Clin Infect Dis: 2009; 49 4 612 622
41. Moreno A, Cervera C, Fortun J, Blanes M, Montejo E, Abradelo M., et al. Epidemiology and outcome of infections in HIV/HCV-coinfected liver transplant recipients: A FIPSE/GESIDA prospective cohort study. Liver Transpl: 2012; 18 1 70 81
42. Berretta M, Garlassi E, Cacopardo B., et al. Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist: 2011; 16 9 1258 1269
43. Rasmussen LD, Dybdal M, Gerstoft J., et al. HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study. HIV Med: 2011; 12 4 202 210
44. Cherian P, Wesal A, Douiri A, Quaglia A, Heneghan M, O'Grady J., et al. Liver transplantation in human immunodeficiency virus infected patients. procoagulant, but is anti thrombotic prophylaxis required? Liver Transpl: 2012; 18 1 82 88
45. Protocol HIVTR: Solid Organ Transplantation in HIV: Multi-Site Study. 2009. Clinical Trials.gov number NCT00074386